Plasma and urinary carnitine and acylcarnitines in chronic fatigue syndrome
Authors:
- C. Stewart GoodwinCGC. Stewart Goodwin
- Saira AmjadSASaira Amjad
- Ronald A. ChalmersRCRonald A. Chalmers
- 1 October 2005
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 360 (1-2) , 173-177
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Fatigue in neurological disordersThe Lancet, 2004
- FatigueBMJ, 2002
- The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and StudyAnnals of Internal Medicine, 1994
- Neurobiological aspects of the chronic fatigue syndromeEuropean Journal of Clinical Investigation, 1994
- Chronic Fatigue Syndrome: A Disease of the Hypothalamic-Pituitary-Adrenal Axis?Annals of Medicine, 1994
- Illness perception and symptom components in chronic fatigue syndromeJournal of Psychosomatic Research, 1992
- Mitochondrial abnormalities in the postviral fatigue syndromeActa Neuropathologica, 1991
- Measurement of L-carnitine and acylcarnitines in body fluids and tissues in children and in adultsClinica Chimica Acta, 1990
- Urinary Excretion of l-Carnitine and Acylcarnitines by Patients with Disorders of Organic Acid Metabolism: Evidence for Secondary Insufficiency of l-CarnitinePediatric Research, 1984
- Secondary carnitine insufficiency in disorders of organic acid metabolism: modulation of acyl-CoA/CoA ratios by l-carnitine in vivoBiochemical Society Transactions, 1983